Medication, lifestyle changes best for kids with T2DM
Children and adolescents newly diagnosed with type 2 diabetes mellitus (T2DM) should be given metformin therapy and dietary and activity guidance as first-line treatments for the disease, says AAP.
View ArticleNew molecular entity: Canagliflozin
On March 29, 2013, FDA approved canagliflozin (Invokana, Janssen Pharmaceuticals, Inc.), a once-daily tablet, indicated as an adjunct to diet and exercise to improve glycemic control in adults with...
View ArticleDapagliflozin as part of triple therapy works well for T2DM
In adult patients with type 2 diabetes mellitus (T2DM) who are uncontrolled on metformin and sulfonylurea, dapagliflozin can be added to help improve HbA1c and reduce fasting plasma glucose, body...
View ArticleEmerging therapies for treating type 2 diabetes
Type 2 diabetes mellitus presents multiple treatment dilemmas for prescribers and healthcare clinicians. The number of oral agents for treating diabetes has increased over the past decade, and the...
View ArticleClik here to view.
What's on the horizon for diabetes therapy?
Diabetes mellitus is a complex, chronic illness that affects approximately 29 million Americans. Optimal management of type 2 diabetes mellitus (T2DM) — which accounts for 90% of all diabetes cases —...
View ArticleClik here to view.
T2DM: Fit the coaching to the patient
When coaching diabetes patients to take their medications as prescribed, pharmacists have two choices: Fit the patient into the world of medicine, or fit the medicine into the world of the patient....
View ArticleClik here to view.
A multifaceted approach to diabetes management
Diabetes mellitus is a severe chronic disease that affects nearly 30 million Americans. Despite advances in the treatment of type 2 diabetes mellitus (T2DM), many patients still remain in suboptimal...
View ArticleClik here to view.
Community pharmacists take on prediabetes
The great rise in the number of people with diabetes is matched by a rise in the prevalence of prediabetes. The Centers for Disease Control and Prevention (CDC) estimates that in 2012, 86 million...
View ArticleClik here to view.
T2DM and CVD: Monitoring by pharmacists empowers patients
Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) are intertwined. T2DM is a major risk factor for CVD, and CVD is the most common cause of death among people with T2DM. Type 2 diabetes...
View Article
